Both in Pharmaceuticals
Keros Therapeutics vs SIGA Technologies
Over the past year KROS returned −23.5% and SIGA returned −60.8%; their daily moves had a correlation of 0.17.
KROS −23.5% SIGA −60.8%Growth of $1, one year, split-adjusted
| Metric | KROS | SIGA |
|---|---|---|
| Price | $11.61 | $3.24 |
| Market cap | $230.2M | $232.4M |
| Today | +1.62% | +1.09% |
| 1 month | +3.8% | −6.0% |
| 6 months | +4.6% | −28.6% |
| Year to date | −43.0% | −47.1% |
| 1 year | −22.8% | −61.6% |
| Revenue growth (YoY) | −100.0% | −49.5% |
| Gross margin | — | 57.2% |
| Net margin | — | 30.4% |
| P/E (TTM) | — | — |
| Price / sales | 15.3× | 4.3× |
| Net cash | $257.6M | $117.6M |
| Dividend yield | — | 18.55% |
| Volatility (60d) | 46.2% | 40.4% |
| Short % of float | 6.2% | 8.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).